FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury

Endoplasmic reticulum (ER) stress is associated with liver injury and fibrosis, and yet the hepatic factors that regulate ER stress-mediated inflammasome activation remain unknown. Here, we report that farnesoid X receptor (FXR) activation inhibits ER stress-induced NACHT, LRR, and PYD domains-conta...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 24; no. 11; pp. 2985 - 2999
Main Authors Han, Chang Yeob, Rho, Hyun Soo, Kim, Ayoung, Kim, Tae Hyun, Jang, Kiseok, Jun, Dae Won, Kim, Jong Won, Kim, Bumseok, Kim, Sang Geon
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 11.09.2018
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Endoplasmic reticulum (ER) stress is associated with liver injury and fibrosis, and yet the hepatic factors that regulate ER stress-mediated inflammasome activation remain unknown. Here, we report that farnesoid X receptor (FXR) activation inhibits ER stress-induced NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome in hepatocytes. In patients with hepatitis B virus (HBV)-associated hepatic failure or non-alcoholic fatty liver disease, and in mice with liver injury, FXR levels in the liver inversely correlated with the extent of NLRP3 inflammasome activation. Fxr deficiency in mice augmented the ability of ER stress to induce NLRP3 and thioredoxin-interacting protein (TXNIP), whereas FXR ligand activation prevented it, ameliorating liver injury. FXR attenuates CCAAT-enhancer-binding protein homologous protein (CHOP)-dependent NLRP3 overexpression by inhibiting ER stress-mediated protein kinase RNA-like endoplasmic reticulum kinase (PERK) activation. Our findings implicate miR-186 and its target, non-catalytic region of tyrosine kinase adaptor protein 1 (NCK1), in mediating the inhibition of ER stress by FXR. This study provides the insights on how FXR regulation of ER stress ameliorates hepatocyte death and liver injury and on the molecular basis of NLRP3 inflammasome activation. [Display omitted] •FXR inhibits ER stress-induced NLRP3 inflammasome activation in hepatocytes•FXR attenuates ER stress-induced hepatocyte death and liver injury•FXR inhibits NLRP3 and TXNIP expression through the PERK-CHOP pathway•miR-186 and its potential target, Nck1, are involved in the ER stress inhibition by FXR Han et al. demonstrate that FXR inhibits ER stress-induced NLRP3 inflammasome activation in hepatocytes. FXR activation ameliorates ER stress-dependent hepatocyte death and liver injury. These findings provide insight into ER stress-mediated inflammasome activation and liver disease progression.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2018.07.068